{"product_id":"the-wiley-handbook-of-anxiety-disorders-isbn-9781118775356","title":"The Wiley Handbook of Anxiety Disorders","description":"\u003cp\u003eThis state-of-the-art Handbook on the research and treatment of anxiety and related disorders is the most internationally and clinically oriented Handbook currently available, encompassing a broad network of researchers, from leading experts in the field to rising stars.\u003c\/p\u003e \u003cul\u003e \u003cli\u003eThe very first handbook to cover anxiety disorders according to the new DSM-5 criteria\u003c\/li\u003e \u003cli\u003ePublished in two volumes, the \u003ci\u003eInternational Handbook\u003c\/i\u003e provides the most wide-ranging treatment of the state-of-the-art  research in the anxiety disorders\u003c\/li\u003e \u003cli\u003eOffers a truly international aspect, including authors from different continents and covering issues of relevance to non-Western countries\u003c\/li\u003e \u003cli\u003eIncludes discussion of the latest treatments, including work on persistence of compulsions, virtual reality exposure therapy, cognitive bias modification, cognitive enhancers, and imagery rescripting\u003c\/li\u003e \u003cli\u003eCovers treatment failures, transdiagnostic approaches, and includes treatment issues for children as well as the older population\u003c\/li\u003e \u003cli\u003eEdited by leaders in the field, responsible for some of the most important advances in our understanding and treatment of anxiety disorders\u003c\/li\u003e \u003c\/ul\u003e \u003cbr\u003e2 Volumes \u003cp\u003eContributors ix\u003c\/p\u003e \u003cp\u003e1 General Introduction 1\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart I Epidemiology and Classification 13\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e2 Nosology and Classification 15\u003cbr\u003e \u003ci\u003eDan J. Stein\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3 Epidemiology and Natural Course 26\u003cbr\u003e \u003ci\u003eKatja Beesdo-Baum and Susanne Knappe\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4 Disability and Costs 47\u003cbr\u003e \u003ci\u003eRonald C. Kessler, Jordi Alonso, Somnath Chatterji, and Yanling He\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5 Anxiety Disorders in Primary Care 58\u003cbr\u003e \u003ci\u003eMichael Kyrios\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6 Cross-cultural Aspects of Anxiety Disorders 69\u003cbr\u003e \u003ci\u003eGurvinder Kalra, Alex Till, and Dinesh Bhugra\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart II Etiology of Anxiety Disorders 83\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e7 Learning Theory 85\u003cbr\u003e \u003ci\u003eYannick Boddez, Frank Baeyens, Dirk Hermans, and Tom Beckers\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8 Cognitive Theory 104\u003cbr\u003e \u003ci\u003eThomas Ehring\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9 Information Processing 125\u003cbr\u003e \u003ci\u003ePeter J. de Jong\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10 Developmental Psychopathology 148\u003cbr\u003e \u003ci\u003eSabine Seehagen, Jürgen Margraf, and Silvia Schneider\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11 Family Factors 172\u003cbr\u003e \u003ci\u003eGuy Bosmans, Eva Vandevivere, Adinda Dujardin, Kathryn Kerns, and Caroline Braet\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12 Emotion Regulation 191\u003cbr\u003e \u003ci\u003eAmelia Aldao and Douglas Mennin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13 Dispositional Basis of Anxiety Disorders 201\u003cbr\u003e \u003ci\u003eDavid Watson and Sara M. Stasik\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14 Genetic Factors and Gene–Environment Interactions 213\u003cbr\u003e \u003ci\u003eEduard Maron and Jakov Shlik\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15 Neuroanatomy and Neuroimaging 233\u003cbr\u003e \u003ci\u003eFrauke Nees and Herta Flor\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e16 Neuroendocrinology and Neurotransmitters 254\u003cbr\u003e \u003ci\u003eJason Gray and Bruce McEwen\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e17 Psychophysiology 274\u003cbr\u003e \u003ci\u003eJens Blechert and Frank H. Wilhelm\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart III Specific Anxiety Disorders and Anxiety-related Disorders 295\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e18 Specific Phobias 297\u003cbr\u003e \u003ci\u003eThomas G. Adams, Craig N. Sawchuk, Joshua M. Cisler, Jeffrey M. Lohr, and Bunmi O. Olatunji\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e19 Panic Disorder and Agoraphobia 321\u003cbr\u003e \u003ci\u003eNorman B. Schmidt, Kristina J. Korte, Aaron M. Norr, Meghan E. Keough, and Kiara R. Timpano\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e20 Social Anxiety Disorder 357\u003cbr\u003e \u003ci\u003eStefan G. Hofmann, B. Turküler Aka, and Alejandra Piquer\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e21 Generalized Anxiety Disorder 378\u003cbr\u003e \u003ci\u003eElizabeth S. Stevens, Alexander A. Jendrusina, Casey Sarapas, and Evelyn Behar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e22 Anxiety Disorders in Children and Adolescents 424\u003cbr\u003e \u003ci\u003eAmie E. Grills, Laura Seligman, and Thomas Ollendick\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e23 Posttraumatic Stress Disorder 457\u003cbr\u003e \u003ci\u003eMichelle J. Bovin, Stephanie Y. Wells, Ann M. Rasmusson, Jasmeet P. Hayes, and Patricia A. Resick\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e24 Obsessive-Compulsive Disorder 497\u003cbr\u003e \u003ci\u003eDavid A. Clark and Adriana del Palacio Gonzälez\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e25 Body Dysmorphic Disorder 535\u003cbr\u003e \u003ci\u003eCorinna M. Elliott, Andrea S. Hartmann, Jennifer L. Greenberg, Anne\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eC. Wilson, and Sabine Wilhelm\u003cbr\u003e \u003c\/i\u003e26 Hypochondriasis 548\u003c\/p\u003e \u003cp\u003e\u003ci\u003eGaby Bleichhardt and Winfried Rief\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e27 Sexual Anxiety 567\u003cbr\u003e \u003ci\u003eNayla Awada, Serena Corsini-Munt, Sophie Bergeron, and Natalie Rosen\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e28 Test Anxiety 581\u003cbr\u003e \u003ci\u003eMoshe Zeidner\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart IV Special Populations 597\u003cbr\u003e \u003c\/b\u003e29 Anxiety Disorders in Older Adulthood 599\u003cbr\u003e \u003ci\u003eAndrew Petkus, Caroline Merz, and Julie Loebach Wetherell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e30 Anxiety Disorders in Non-Western Countries 612\u003cbr\u003e \u003ci\u003eToshi A. Furukawa\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart V Prevention 623\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e31 Prevention of Anxiety Disorders 625\u003cbr\u003e\u003ci\u003eHeidi J. Lyneham, Ronald M. Rapee, and Jennifer L. Hudson\u003cbr\u003e\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart VI Clinical Assessment 643\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e32 Clinical Assessment of Anxiety Disorders 645\u003cbr\u003e\u003ci\u003eSusanne Knappe and J¨urgen Hoyer\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e33 Case Formulation 692\u003cbr\u003e\u003ci\u003ePeter Sturmey\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e34 Routine Outcome Monitoring in Anxiety Disorders 706\u003cbr\u003e\u003ci\u003eMichael J. Lambert and Madeline R. Greaves\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart VII Treatment of Anxiety Disorders: State of the Art 715\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e35 Exposure Therapy 717\u003cbr\u003e\u003ci\u003eMichael J. Telch, Adam R. Cobb, and Cynthia L. Lancaster\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e36 Cognitive Therapy 757\u003cbr\u003e\u003ci\u003eAnna N. Vossbeck-Elsebusch and Thomas Ehring\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e37 Metacognitive Therapy 776\u003cbr\u003e\u003ci\u003eAdrian Wells and Kirsten McNicol\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e38 Transdiagnostic CBT for Anxiety Disorders 787\u003cbr\u003e\u003ci\u003eTerri L. Barrera, Angela H. Smith, and Peter J. Norton\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e39 Mindfulness and Acceptance-based Behavioral Therapies 804\u003cbr\u003e\u003ci\u003eLizabeth Roemer, Jessica R. Graham, Lucas Morgan,and Susan M. Orsillo\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e40 Mechanisms of Change in CBT Treatment 824\u003cbr\u003e\u003ci\u003eBethany A. Teachman, Jessica R. Beadel, and Shari A. Steinman\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e41 Interpersonal and Emotion-focused Processing Psychotherapy 840\u003cbr\u003e\u003ci\u003eMichelle G. Newman, Nicholas C. Jacobson, and Louis G. Castonguay\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e42 Psychodynamic Therapy of Anxiety Disorders 852\u003cbr\u003e\u003ci\u003eFalk Leichsenring, Susanne Klein, and Simone Salzer\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e43 Pharmacological Treatment of Anxiety Disorders 865\u003cbr\u003e\u003ci\u003eDavid S. Baldwin and Emma K. Brandish\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e44 Combination Treatment of Psychological Treatment and Pharmacotherapy 883\u003cbr\u003e\u003ci\u003eAnton J. L. M. van Balkom, Neeltje Batelaan, and Gerthe Veen\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart VIII Clinical Management of Specific Anxiety Disorders and Anxiety-related Disorders 895\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e45 Specific Phobias: Assessment and Treatment 897\u003cbr\u003e\u003ci\u003eAlfons O. Hamm\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e46 Panic Disorder: Assessment and Treatment 924\u003cbr\u003e\u003ci\u003eKristin L. Szuhany, M. Alexandra Kredlow, and Michael W. Otto\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e47 Social Anxiety Disorder: Assessment and Treatment 964\u003cbr\u003e\u003ci\u003eDenise M. Ginzburg, Franziska Schreiber, and Ulrich Stangier\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e48 Generalized Anxiety Disorder: Assessment and Treatment 1003\u003cbr\u003e\u003ci\u003eAlexander L. Gerlach and Stephan Stevens\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e49 Anxiety Disorders in Children and Adolescents: Assessment and Treatment 1038\u003cbr\u003e\u003ci\u003eCara A. Settipani, Douglas M. Brodman, Jeremy Peterman, Kendra L. Read, Alexandra L. Hoff, Anna J. Swan, and Philip C. Kendall\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e50 Posttraumatic Stress Disorder: Assessment and Treatment 1078\u003cbr\u003e\u003ci\u003eMadhur Kulkarni, Alex Barrad, and Marylene Cloitre\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e51 Obsessive-Compulsive Disorder: Assessment and Treatment 1111\u003cbr\u003e\u003ci\u003eAmitai Abramovitch, Corinna M. Elliott, Gail Steketee,Anne C. Wilson, and Sabine Wilhelm\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart IX Clinical Management of Comorbidity 1145\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e52 Treatment of Comorbid Anxiety Disorders and Substance Use Disorder 1147\u003cbr\u003e\u003ci\u003eMatt G. Kushner\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e53 Treatment of Comorbid Anxiety Disorders and Depression 1165\u003cbr\u003e\u003ci\u003eGiovanni A. Fava and Elena Tomba\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e54 Treatment of Comorbid Anxiety Disorders and Personality Disorders 1183\u003cbr\u003e\u003ci\u003eArnoud Arntz\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart X Approaches to Improve Effectiveness and Dissemination 1195\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e55 Cognitive-Behavior Therapy for Anxiety Disorders:When Intervention Fails 1197\u003cbr\u003e\u003ci\u003eDean McKay, Justin Arocho, and Joseph Brand\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e56 Addressing Patient Motivation, Therapeutic Alliance, and Treatment Expectancies in Interventions for Anxiety Disorders 1215\u003cbr\u003e\u003ci\u003eAlessandro S. De Nadai, Morgan A. King, Marc S. Karver,and Eric A. Storch\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e57 Dissemination and Implementation of Evidence-based Treatments 1228\u003cbr\u003e\u003ci\u003eSeth J. Gillihan, Phoebe Conklin, and Edna B. Foa\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e58 Self-help Treatments and Stepped Care 1242\u003cbr\u003e\u003ci\u003eRosemary Webster, Andrew Thompson, Thomas L. Webb,and Paschal Sheeran\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e59 The Cost-effectiveness of Treatments for Anxiety Disorders 1256\u003cbr\u003e\u003ci\u003eCathrine Mihalopoulos, Amanda J. Baxter, Harvey Whiteford, and Theo Vos\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e60 Assessment and Treatment in Non-Western Countries 1268\u003cbr\u003e\u003ci\u003eDevon E. Hinton\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e61 Guided Internet Treatment of Anxiety Disorders in Adults 1279\u003cbr\u003e\u003ci\u003eGerhard Andersson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e62 Internet Treatment of Youth 1297\u003cbr\u003e\u003ci\u003eSonja March, Susan H. Spence, and Caroline L. Donovan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e63 Virtual Reality Exposure Therapy 1310\u003cbr\u003e\u003ci\u003eKatharina Meyerbr¨oker\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e64 Cognitive Bias Modification Training 1325\u003cbr\u003e\u003ci\u003eBen Grafton and Colin MacLeod\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e65 Cognitive Enhancers as Adjuncts to Exposure-based Treatments 1343\u003cbr\u003e\u003ci\u003eBram Vervliet and Ellen Vervoort\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e66 Deep Brain Stimulation 1355\u003cbr\u003e\u003ci\u003ePieter Ooms, Pelle P. de Koning, and Damiaan Denys\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart XI Agenda for Future Research 1369\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e67 Psychiatric Perspective 1371\u003cbr\u003e\u003ci\u003eRichard van Dyck, Anton J. L. M. van Balkom,Odile A. van den Heuvel, and Christel M. Middeldorp\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e68 Psychological Perspective 1382\u003cbr\u003e\u003ci\u003eThomas Ehring and Paul Emmelkamp\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIndex 1391\u003c\/p\u003e \u003cp\u003e\u003ci\u003e \u003c\/i\u003e\u003c\/p\u003e  \u003cp\u003e\u003cb\u003ePaul Emmelkamp\u003c\/b\u003e is a Professor of Clinical Psychology at the University of Amsterdam and a registered clinical psychologist and psychotherapist. His research in this area focuses on the aetiology and treatment of anxiety disorders, posttraumatic stress disorder and OCD and the role of co-morbidity. He is the founding editor of \u003ci\u003eClinical Psychology \u0026amp; Psychotherapy\u003c\/i\u003e and editor of \u003ci\u003eBMC-Psychiatry\u003c\/i\u003e. He is the author of \u003ci\u003eEvidence-based treatment for Alcohol and Drug Abuse\u003c\/i\u003e (with E. Vedel, 2006) and of \u003ci\u003ePersonality Disorders\u003c\/i\u003e (with J. H. Kamphuis, 2007).\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003eThomas Ehring\u003c\/b\u003e is a Professor of Clinical Psychology and Psychotherapy at the University of Münster, Germany, as well as a registered clinical psychologist and Director of the Centre for PTSD Treatment at Münster University. He has authored many journal articles as well as contributing chapters to several books including \u003ci\u003eCognitive Behavioral Theories in Clinical Practice\u003c\/i\u003e (2009).  \u003c\/p\u003e  \u003cp\u003eThis state-of-the-art Handbook on the research and treatment of anxiety and related disorders is the most clinically-oriented Handbook currently available. It offers a truly international approach, encompassing a broad network of researchers and covering issues of global -- not just Western -- relevance.\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e Divided into two volumes, the first reflects the state of the art of theory and research in the field;  the second volume focuses primarily on clinical applications. Volume 1 covers various aspects related to theory and research into anxiety disorders, including epidemiology, course, classification according to DSM-5, and major etiological approaches. Disorder-specific chapters provide in-depth information on each anxiety disorder as well as number of anxiety-related problems classified in other categories, including PTSD, OCD, sexual anxiety, and body dysmorphic disorders. Volume 2 presents the very latest treatments for anxiety disorders. Chapters cover the most recent research findings in the areas, as well as clinically relevant information including brief case vignettes. In addition to established treatments, new and innovative approaches are covered, including cognitive bias modification, virtual reality exposure therapy, deep brain stimulation and the use of cognitive enhancers.  \u003cp\u003eThis impressive two-volume handbook includes coverage of almost anything one could want to know about anxiety disorders – theory, epidemiology, assessment, and multiple aspects of treatment. The authors’ list is a who’s who of experts in anxiety disorders. This book will be of great use to anxiety researchers as well as to students and practitioners in this field.\u003cbr\u003e —\u003cb\u003e\u003ci\u003eProfessor Dianne L. Chambless\u003c\/i\u003e, University of Pennsylvania\u003c\/b\u003e\u003c\/p\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47990371385573,"sku":"NP9781118775356","price":454.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781118775356.jpg?v=1761787554","url":"https:\/\/k12savings.com\/products\/the-wiley-handbook-of-anxiety-disorders-isbn-9781118775356","provider":"K12savings","version":"1.0","type":"link"}